| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |